System‑wide Insights via a Single Sample:Cloud‑Clone CBA Ushers in a New Era for Neuro‑Endocrine‑Immune Network Research

A pre-validated 36-plex panel enables simultaneous profiling of hormones and inflammatory mediators on standard flow cytometer

HUSTON, TX, UNITED STATES, August 26, 2026 /EINPresswire.com/ — As systems-biology research advances, it is widely acknowledged that complex disease pathologies rarely stem from dysregulation of a single molecular target. Instead, illnesses often arise from imbalances across interconnected neuro-endocrine-immune signalling axes. Conventional single-biomarker testing workflows create notable experimental pain points: precious biological samples are rapidly exhausted through repeated separate tests, batch-to-batch variance undermines data reliability, and technical gaps prevent synchronous measurement of neuroendocrine hormones alongside immune cytokines. Cloud-Clone addresses these challenges with its CBA (Cytometric Bead Array) workflow, introducing a fully-validated 36-plex panel built to profile the complete neuro-endocrine-immune network, delivering comprehensive system-level readouts starting from a single sample aliquot.
Complex diseases are not driven by the activity of one isolated molecule, but by crosstalk among the nervous, endocrine and immune systems. Traditional testing approaches leave researchers with incomplete datasets. Repeated single-target measurements deplete limited sample material, inconsistent assay performance introduces batch noise, and methodological differences make concurrent detection of neuroendocrine hormones and immune cytokines difficult to achieve.
Researchers face core practical questions: how can users capture dynamic shifts in stress hormones alongside inflammatory cascades from one small-volume sample? How can widely-deployed laboratory flow cytometers be repurposed as high-throughput protein quantitation platforms? Cloud-Clone provides a solution via its CBA (Cytometric Bead Array) technology. The newly launched 36-plex assay panel covers key analytes across the full neuro-endocrine-immune spectrum and makes system-wide profiling achievable from a single sample.
Technical innovation: combining flow cytometry with bead-based liquid-phase immunoassays

Cloud-Clone CBA merges the high specificity of classic antigen-antibody interactions with the high-throughput strengths of flow cytometry, built around a system of precisely fluorescence-encoded microspheres.
1.Encoded microspheres: Each set of microspheres with distinct fluorescent intensity is conjugated with capture antibodies for a defined target analyte, assigning a unique molecular “identifier” for every biomarker of interest.
2.Liquid-phase sandwich complex formation: Within a homogenous near-physiological reaction environment, microspheres capture target molecules present in samples. Fluorescently labelled detection antibodies subsequently bind to form complete sandwich immune-complexes.
3.Flow-cytometric decoding: Standard flow cytometers equipped with APC, PE and APC-Cy7 channels read bead identifiers for target identification, and measure reporter-fluorescence intensity to calculate protein concentrations.
This technical design removes dependence on dedicated proprietary instruments such as Luminex systems. Existing laboratory flow cytometers can be repurposed for high-multiplex protein quantitation, substantially lowering the hardware barrier for high-throughput biomarker profiling.
Proven assay performance: robust analytical metrics built on extensive antibody resources
Reliable multiplex assays demand stringent validation for antibody specificity and matrix compatibility. Drawing from Cloud-Clone’s in-house library of more than 27 000 antibodies, every panel undergoes thorough testing for cross-reactivity and matrix interference.
Key analytical performance benchmarks are listed below:
-Sensitivity: Assay limits-of-detection reach pg/mL range, enabling measurement of low-abundance molecular shifts missed by conventional detection tools.
-Accuracy: Spike-and-recovery values consistently fall within 80%-120%, and serially diluted samples deliver linear response with R² ≥0.97.
-Reproducibility: Strong batch-to-batch consistency and comparable datasets are maintained across different instrument platforms of flow cytometers.

36-plex panel: key analytes for dissecting neuro-endocrine-immune crosstalk
This newly released pre-validated 36-plex panel is tailored for research scenarios including stress response, cardiovascular injury and autoimmune pathology. It bridges historical separation between hormone testing and cytokine measurement within one single reaction well, divided into two functional modules.
Module 1: Neuro-endocrine and cardiovascular homeostasis (9 analytes) This set includes key mediators from the RAAS system (ALD, AngII), cardiac functional markers (ANP, BNP), sympathetic-adrenal signalling molecules (EPI, NE) and vascular endothelial mediators (EDN1). Parallel measurement of these biomarkers supports direct investigation linking stress perturbation and downstream immune remodelling.
Module 2: Full-spectrum immune-inflammatory network (27 analytes) The panel covers signature mediators from Th1/Th2/Th17 T-cell subsets (IL-2, IFN-γ, IL-4, IL-17), balances pro-inflammatory (TNF-α, IL-1β) and anti-inflammatory signals (IL-10), chemokines such as IP-10, haematopoiesis regulators including GM-CSF, as well as non-canonical cytokines such as IL-16.
Running all analytes in one single experiment using identical sample material allows researchers to characterise how neuro-endocrine activation drives immune deviation, supplying high-confidence datasets for mechanistic system-level investigations.
Application scenarios & custom service capabilities
-Cardiorenal disease research: Synchronously profile RAAS activation, cardiac injury markers and systemic inflammatory networks to unpack pathological loops behind heart and kidney impairment.
-Stress and trauma model studies: Document dynamic changes of CRF and catecholamines alongside remodelling in innate and adaptive immune responses.
-Autoimmunity and drug evaluation: Characterise how candidate therapeutics modulate neuro-endocrine homeostasis while monitoring global shifts across inflammatory mediator networks.
Beyond pre-configured validated panels, Cloud-Clone offers custom panel development drawing upon a catalogue of over 7 000 detectable analytes. Every production step, from antibody raw material preparation to finished kit assembly, is managed internally. Researchers can obtain high-throughput assay solutions aligned with unique experimental requirements.
Single-analyte testing restricts researchers to partial snapshots of complex biological systems. Cloud-Clone CBA multiplex technology empowers laboratories to capture holistic biological read-outs from minimal sample input. By unlocking the multiplex-testing potential of widely-available flow cytometry instruments, this panel expands research capacity for systems-biology work focused on neuro-endocrine-immune crosstalk across global research communities.

SuKi Duan
CLOUD-CLONE CORP.WUHAN
email us here
Visit us on social media:
LinkedIn
Instagram
TikTok
X

Media gallery

About The Author

Written By: EIN Presswire